MARKET

TRIB

TRIB

Trinity Biotech Plc
NASDAQ
0.6054
-0.0136
-2.20%
Pre Market: 0.5880 -0.0174 -2.87% 07:47 04/08 EDT
OPEN
0.5852
PREV CLOSE
0.6190
HIGH
0.6199
LOW
0.5852
VOLUME
156
TURNOVER
0
52 WEEK HIGH
3.440
52 WEEK LOW
0.4800
MARKET CAP
11.33M
P/E (TTM)
-0.2730
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TRIB last week (0330-0403)?
Weekly Report · 2d ago
Trinity Biotech interim CFO Paul Murphy files initial beneficial ownership statement
Reuters · 5d ago
Trinity Biotech director John Gillard files initial beneficial ownership statement
Reuters · 5d ago
Trinity Biotech director Andrew Omidvar files initial beneficial ownership statement
Reuters · 5d ago
Weekly Report: what happened at TRIB last week (0323-0327)?
Weekly Report · 03/30 09:24
Trinity Biotech Reports Strong EpiCapture Prostate Cancer Trial Results and Secures Debt Covenant Waiver
TipRanks · 03/25 13:38
Trinity Biotech reports 85% AUC in 750-sample study of enhanced EpiCapture prostate cancer test; commercialization plans advance via New York reference laboratory
Reuters · 03/25 13:13
Trinity Biotech reports 85% AUC in 750-sample clinical study of enhanced EpiCapture prostate cancer test
Reuters · 03/24 13:52
More
About TRIB
Trinity Biotech plc is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemical parameters in serum, plasma and whole blood, and the Company intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its TrinScreen Human Immunodeficiency Virus (HIV) rapid point-of-care test is a high-quality, single-use immunoassays to aid in the diagnosis of HIV. The Uni-Gold range of rapid point-of-care test devices consist of high-quality, single-use immunoassays to aid in the diagnosis of HIV.

Webull offers Trinity Biotech PLC (ADR) stock information, including NASDAQ: TRIB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TRIB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TRIB stock methods without spending real money on the virtual paper trading platform.